Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. [PDF]
, 2016 INTRODUCTION: Introduction of new antibiotics enabling single-dose administration, such as oritavancin may significantly impact site of care decisions for patients with acute bacterial skin and skin structure infections (ABSSSI).
C Marwick +8 more
core +2 more sources
Comparison of Digital Planimetry and Ruler Technique To Measure ABSSSI Lesion Sizes in the ESTABLISH–1 Study [PDF]
Surgical Infections, 2014 In August 2010, the U.S. Food and Drug Administration issued draft guidelines for developing antibiotics for treating acute bacterial skin and skin structure infections (ABSSSI), with the outcome measure of such treatment relying primarily on the cessation of spread or on the decrease in size of skin lesions at 48-72 h after the initiation of such ...
Paul, Bien +2 more
openaire +2 more sources
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline [PDF]
, 2015 Objectives: Bacterial skin and skin-structure infections (SSSIs) are frequent settings for antibiotic use. We surveyed their UK aetiology and pathogen susceptibility, including susceptibility to ceftaroline.
James, Dorothy +5 more
core +1 more source
BMC Health Services Research, 2018 Background Limited research has assessed patient preferences for treatment disposition and antibiotic therapy of acute bacterial skin and skin structure infection (ABSSSI) in the emergency department (ED).
Safa S. Almarzoky Abuhussain +10 more
doaj +1 more source
Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections
European Medical Journal, 2022 Hospitalisation rates for acute bacterial skin and skin structure infection (ABSSSI) are rising and represent a large pharmacoeconomic burden as treatment may involve an extended number of days of antibiotic therapy. This article first aims to provide a
Gavin Barlow +2 more
doaj +1 more source
461. Management of ABSSSIs: An Assessment of Knowledge, Competence and Clinical Practices among ID Specialists [PDF]
Open Forum Infectious Diseases, 2019 Abstract Background One of the most common bacterial infections overall and among the most common causes for ED referral and/or hospital admission, ABSSSIs continue to impart a significant public health burden.
Hurst, Simi Thomas, Maeglin, John
openaire +1 more source
Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
Therapeutics and Clinical Risk Management, 2021 Oriana Simonetti,1,* Giulio Rizzetto,1,* Elisa Molinelli,1 Oscar Cirioni,2 Annamaria Offidani1 1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 2Clinic of Infectious Diseases ...
Simonetti O +4 more
doaj
Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production [PDF]
, 2016 Semi-synthetic derivatives of the tricyclic diterpene antibiotic pleuromutilin from the basidiomycete Clitopilus passeckerianus are important in combatting bacterial infections in human and veterinary medicine.
Alberti, Fabrizio +13 more
core +3 more sources
Kimyrsa and Orbactiv – A Tale of Two Formulations
Drug Design, Development and Therapy, 2023 Brittany T Jackson,1 David B Cluck,2 Andrés F Henao-Martínez,3 Daniel B Chastain4 1Department of Pharmacy, Mount Sinai Morningside, New York, NY, 10025, USA; 2Department of Pharmacy Practice, Bill Gatton College of Pharmacy East Tennessee State ...
Jackson BT +3 more
doaj
Infectious Diseases and Therapy, 2019 Introduction Admissions for acute bacterial skin and skin structure infections (ABSSSI) are often prolonged because of intravenous (IV) antibiotics. Use of a long-acting IV antibiotic may reduce length of stay (LOS) on a hospitalist service.
Matthew W. McCarthy +6 more
doaj +1 more source